This information is intended for Canadian residents.
Sanofi is a leader in the global pharmaceutical market, with an extensive line of prescription medicines. Links to comprehensive information about our pharmaceutical products are listed below, most frequently in the form of a product monograph.
This information has been approved by Health Canada and should be read and discussed in consultation with a health care professional.
Admelog™ and Admelog™
SoloSTAR®
(insulin lispro injection)
AllStar® Pro
Alprolix®
(coagulation factor IX (recombinant), Fc fusion protein)
Apidra®
(insulin glulisine)
Avalide®
(irbesartan, hydrochlorothiazide)
Eloctate®
(antihemophilic factor (recombinant BDD), Fc fusion protein )
Glucophage®
Trademark of Merck Santé s.a.s. Commercialized in Canada by sanofi-aventis. (metformin hydrochloride)
JuniorSTAR®
Kayexalate®
(sodium polystyrene sulfonate)
Lantus®
(insuline glargine)
- PRODUCT MONOGRAPH
- PATIENT MEDICATION INFORMATION
- LANTUS® SOLOSTAR® INSTRUCTION LEAFLET
- SOLOSTAR® QUICK GUIDE
- LANTUS® REIMBURSEMENT IN QUEBEC
For more information, contact Sanofi Canada at 1-888-852-6887
MabCampath®
(alemtuzumab)
Multaq®
(dronedarone tablets)
- PRODUCT MONOGRAPH
- PATIENT MEDICATION INFORMATION
- RISK MINIMIZATION TOOL FOR HEALTHCARE PROFESSIONALS – CONTACT OUR MEDICAL INFORMATION DEPARTMENT
- SAFETY INFORMATION FOR THE PUBLIC - AUG. 4 2011 (PERMANENT ATRIAL FIBRILLATION)
- SAFETY INFORMATION FOR HEALTHCARE PROFESSIONALS - JULY 29 2011 (PERMANENT ATRIAL FIBRILLATION)
- SAFETY INFORMATION FOR THE PUBLIC - MARCH 15 2011 (LIVER INJURY)
- SAFETY INFORMATION FOR HEALTHCARE PROFESSIONALS - MARCH 10 2011 (HEPATOCELLULAR LIVER INJURY)
- INFORMATION FOR HEALTH PROFESSIONALS (PALLAS STUDY AND PULMONARY SAFETY)
- INFORMATION FOR THE PUBLIC (PALLAS STUDY)
Nitrolingual® Pumpspray
Trademark of G. Pohl-Boskamp GmbH & Co. Commercialized in Canada by sanofi-aventis. (nitroglycerin)
Plaquenil®
(hydroxychloroquine sulfate)
Renagel®
(sevelamer hydrochloride tablets)
Renvela®
(sevelamer carbonate tablets)
Sarclisa™
(isatuximab for injection)
Sofracort®
(framycetin sulphate, gramicidin, dexamethasone)
Soliqua®
(insulin glargine and lixisenatide for injection)
Synvisc® /Synvisc-One®
(hylan G-F 20)
Toujeo® SoloSTAR® Toujeo®
DoubleSTAR®
(insulin glargine)
Xatral®
(alfuzosin hydrochloride)